Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
ProQR Therapeutics N.V. (NASDAQ: PRQR)
PRQR Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-7%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
331%
PRQR Stock Analysis
PRQR
PE Ratio:
PRQR
PEG Ratio:
Not Available
PRQR
Forward EPS Growth (12 month):
0.00%
PRQR
PS Ratio:
9.9
PRQR
PSG Ratio:
Not Available
PRQR
Forward Revenue Growth (12 month):
0.00%
PRQR Articles
No data was found